Skip to content

The effect of weight loss surgery on cardiovascular haemodynamics in adults with obesity

The effect of weight loss surgery on cardiovascular haemodynamics in adults with obesity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12624000868583
Enrollment
40
Registered
2024-07-16
Start date
2022-04-26
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Obesity continues to be a major public health concern in Australia and overseas. In particular, obesity contributes to changes in the heart’s blood flow in the form of increased circulating blood volume, cardiac output, systolic blood pressure and pulmonary pressures. Long-term, these lead to the development of heart failure, atrial fibrillation and ischaemia. Furthermore, fat deposited around the heart is associated with the development of a specific type of heart failure common in individuals with obesity. Hence, obesity is considered an important risk factor for cardiovascular disease. However, there is growing evidence that effective management of obesity also improves cardiovascular outcomes for patients. Bariatric surgery, an established treatment for weight loss, has been shown to reduce the incidence of cardiovascular risk factors and heart attacks. In this study, we seek to assess the impact of bariatric surgery on the heart’s structures and blood flow using cardiac magnetic resonance imaging (CMR). Although ultrasound technology or echocardiography is widely used for assessing such features, challenges remain when acquiring accurate images in those with obesity. CMR offers an opportunity to overcome some of these imaging challenges. CMR is less user dependent compared to echocardiography and has demonstrated excellent feasibility in this population. We hypothesize that bariatric surgery will lead to a decrease in cardiac output, and reductions in the degree of fibrosis of the heart muscle and the volume of fat around the heart as measured by pre- and post-surgery CMR, thus reducing cardiovascular disease risk. Eighty participants will be recruited for this study. Assessments will include cardiac imaging scans, measurement of exercise capacity, blood tests, and quality of life questionnaires. These will be performed before and 12 months after their bariatric surgery.

Interventions

We will assess the impact of bariatric surgery on adults with obesity. Participants will be followed up 12 months after their surgery. Participants will be assessed before and 12 months after their bariatric surgery. Each face-to-face visit is estimated to take approximately three hours to complete. This will include a cardiac MRI (~1hr); echocardiogram and 6-minute walk test (~1hr); anthropometric measurements, quality of life questionnaires, and blood collection (~10 tubes for cholesterol, glu

We will assess the impact of bariatric surgery on adults with obesity. Participants will be followed up 12 months after their surgery. Participants will be assessed before and 12 months after their bariatric surgery. Each face-to-face visit is estimated to take approximately three hours to complete. This will include a cardiac MRI (~1hr); echocardiogram and 6-minute walk test (~1hr); anthropometric measurements, quality of life questionnaires, and blood collection (~10 tubes for cholesterol, glucose, other biomarkers) to take the remaining time. The MRI and echocardiogram will be performed by trained imaging technicians supervised by a cardiologist. Blood samples will be taken by a qualified blood collector. Other assessments will be performed by trained research staff.

Sponsors

Nepean Blue Mountains Local Health District
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Individuals with a BMI >= 30 Weight <200kg Individuals suitable for bariatric surgery

Exclusion criteria

Contraindication to MRI Unable to provide a valid consent to participate in the study Known cardiovascular disease Claustrophobia Pregnancy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026